In preclinical studies, in animal models of AD, this drug increased the size of the hippocampus and dentate gyrus and promoted the expression of proteins related to the activation of the CREB/BDNF signaling pathways [60]. The gene discussed is BDNF; the disease is Alzheimer disease.